ResMed Inc. (FRA:RME)

Market Cap	31.88B
Revenue (ttm)	4.65B
Net Income (ttm)	1.22B
Shares Out	n/a
EPS (ttm)	8.24
PE Ratio	26.24
Forward PE	24.97
Dividend	1.95 (0.89%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	45
Open	220.00
Previous Close	222.00
Day's Range	220.00 - 220.00
52-Week Range	170.30 - 248.90
Beta	n/a
RSI	49.63
Earnings Date	Aug 1, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RME

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD